[Latest advances in the diagnosis and treatment of Marfan syndrome]. / 马æ¹ç»¼åå¾çææ°è¯çè¿å±.
Zhongguo Dang Dai Er Ke Za Zhi
; 24(7): 826-831, 2022 Jul 15.
Article
en Zh
| MEDLINE
| ID: mdl-35894201
ABSTRACT
Marfan syndrome (MFS) is a multisystem connective tissue disease with autosomal dominant inheritance. It is mainly caused by FBN1 gene mutation and often has different clinical manifestations. Neonatal MFS is especially rare with severe conditions and a poor prognosis. At present, there is still no radical treatment method for MFS, but early identification, early diagnosis, and early treatment can effectively prolong the life span of patients. This article reviews the latest advances in the diagnosis and treatment of MFS.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Síndrome de Marfan
Tipo de estudio:
Diagnostic_studies
/
Prognostic_studies
/
Screening_studies
Límite:
Humans
/
Newborn
Idioma:
Zh
Año:
2022
Tipo del documento:
Article